证券记录 · 已归档季度
MYGN
Myriad Genetics, Inc. · Healthcare · Medical - Diagnostics & Research
16被追踪持有人
0Δ持有人
51.45M持有股份
$273.22M报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +3.3% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 966.11K | $4.16M | n/a | n/a |
| Q2 2026 | 84 | -4 | 70.39M | $401.85M | +6 | −11 |
| Q1 2026 | 92 | -3 | 73.19M | $329.45M | +3 | −6 |
| Q4 2025 | 95 | 0 | 80.50M | $495.06M | n/a | n/a |
| Q3 2025 | 19 | 0 | 56.51M | $408.57M | n/a | n/a |
| Q2 2025 | 16 | 0 | 51.45M | $273.22M | +1 | −1 |
| Q1 2025 | 13 | 0 | 25.12M | $222.86M | +1 | −1 |
| Q4 2024 | 13 | -1 | 27.01M | $370.33M | n/a | −1 |
| Q3 2024 | 13 | +3 | 18.94M | $518.67M | +3 | n/a |
| Q2 2024 | 10 | n/a | 22.76M | $556.69M | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 15.07M | n/a | $80.03M | 0.0% | n/c | 1 | SEC ↗ ×17 |
| 2 | The Vanguard Group ✦ (被动) | 9.26M | n/a | $49.16M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | Millennium Management ✦ | 4.92M | +21.0% | $26.15M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (被动) | 4.81M | -8.7% | $25.54M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Glenview Capital ✦ | 4.59M | +17.6% | $24.36M | 0.7% | ▲ Add | 5 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 4.51M | +78.8% | $23.96M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Geode Capital Management ✦ (被动) | 2.22M | -0.3% | $11.81M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 8 | Citadel Advisors ✦ | 1.71M | +219.7% | $9.09M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Fisher Asset Management ✦ | 1.29M | +20.4% | $6.88M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 1.06M | +144.3% | $5.62M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 11 | Two Sigma Investments ✦ | 544.45K | +3654.9% | $2.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Point72 Asset Management ✦ | 538.06K | +190.8% | $2.86M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 448.37K | +79.5% | $2.38M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 348.71K | n/a | $1.85M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 15 | Marshall Wace ✦ | 68.03K | 新增 | $361,219 | 0.0% | New | 1 | SEC ↗ ×2 |
| 16 | T. Rowe Price ✦ | 55.18K | +14.6% | $293,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $361,219 | 0.0% |
已清仓
| Wellington Management | $40.73M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 200 持有人, 87.60M 股份, $371.14M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
Sep 04
SC 13G: BlackRock Portfolio Management LLC
Aug 14
SC 13G/A: GLENVIEW CAPITAL MANAGEMENT, LLC
Aug 14
SC 13G: Vestal Point Capital, LP
Aug 07
SC 13G: STATE STREET CORP
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据